[4]
Abbott is appealing the Orders on the grounds that there was no evidence before Prothonotary Milczynski to support any of Novopharm's assertions of confidentiality and the limited form of protection contained in the Orders.
2. BACKGROUND
The Application and the Protective Order Motion